Johnson & Johnson announces approval of OPSYNVI for pulmonary arterial hypertension patients
In a significant milestone for pulmonary arterial hypertension (PAH) patients, Johnson & Johnson has announced the approval of OPSYNVI.
Archives for March 25, 2024
With 90% of rare disease patients feeling depressed, what can be done?
The Undiagnosed Diseases Network Foundation (UDNF) has successfully co-led a critical discussion on mental health at the 2024 Rare Disease Summit.
Denmark and NVIDIA forge alliance to establish AI supercomputer
Denmark says it is poised to revolutionize its technological landscape through a collaboration with multinational corporation NVIDIA, aimed at establishing a national center for AI innovation.
CluePoints on overcoming scepticism and the benefits of AI to optimize trial strategies
Patrick Hughes, co-founder and chief commercial officer of Cluepoints and OSP caught up for an in-person discussion during SCOPE 2024 to find out what developments the company had been working on and how they are benefiting from using AI.